AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

OPKO Health Inc.

Regulatory Filings Jan 5, 2021

6963_rns_2021-01-05_7471388b-6e35-4d08-9794-9d1a26ce5280.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

MIAMI (January 5, 2021) – OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39 th Annual J.P. Morgan Healthcare Conference being held virtually on January 11- 14, 2021. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 13 th at 3:40 p.m. Eastern time.

The presentation will be webcast live and available for replay in the Investors section of OPKO Health's website and accessible by clicking here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industryleading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations Yvonne Briggs, 310-691-7100 [email protected] or Bruce Voss, 310-691-7100 [email protected]

#

Talk to a Data Expert

Have a question? We'll get back to you promptly.